| MolName | (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-5-[[4-(2-hydroxyethoxy)phenyl]methyl]-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide |
| MolecularFormula | C41H46N2O6 |
| Smiles | OCCOc1ccc(C[C@@H](C[C@@H]2Cc3ccccc3)N(C[C@H](C[C@@H](Cc3ccccc3)C(N[C@H]([C@@H](C3)O)c4c3cccc4)=O)O)C2=O)cc1 |
| InChI | InChI=1S/C41H46N2O6/c44-19-20-49-36-17-15-30(16-18-36)23-34-24-33(22-29-11-5-2-6-12-29)41(48)43(34)27-35(45)25-32(21-28-9-3-1-4-10-28)40(47)42-39-37-14-8-7-13-31(37)26-38(39)46/h1-18,32-35,38-39,44-46H,19-27H2,(H,42,47)/t32-,33+,34-,35+,38-,39+/m1/s1 |
| InChIK | WGDGPLAUVPABOV-IWUMVIHASA-N |
| TotalMolweight | 662.824 |
| Molweight | 662.824 |
| MonoisotopicMass | 662.335588 |
| CLogP | 5.314 |
| CLogS | -5.881 |
| H Acceptors | 8 |
| H Donors | 4 |
| TotalSurfaceArea | 510.69 |
| Relative PSA | 0.177 |
| PolarSurfaceArea | 119.33 |
| Druglikeness | 5.2182 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.44898 |
| Fragments | 1 |
| Non HAtoms | 49 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 6 |
| Rotatable Bond | 15 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 19 |
| Symmetricatoms | 6 |
| Amides | 2 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-5-[[4-(2-hydroxyethoxy)phenyl]methyl]-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide | 2 - (2R,4S)-2-benzyl-5-[(3S,5R)-3-benzyl-5-[[4-(2-hydroxyethoxy)phenyl]methyl]-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide